DNA read, write, and edit market to hit $67.7B by 2030, driven by CRISPR and genomic diagnostics growth

The global market for DNA read, write, and edit technologies is projected to grow from $21.4 billion in 2024 to $67.7 billion by 2030, at a CAGR of 21.2%. This rapid growth is fueled by expanding clinical applications of genome editing, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics. North America leads the market with 43.5% share due to strong genomics research and pharmaceutical R&D. Key drivers include early disease detection, infectious disease monitoring, and advances in gene editing therapies. Investors should watch regulatory changes and competition among sequencing and gene editing companies as the market evolves.